Microbix Biosystems Inc. (MBX.TO)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Cameron L. Groome | President, CEO & Director | 416.65k | -- | -- |
| Mr. James S. Currie | Chief Financial Officer | 266.51k | -- | -- |
| Dr. Kenneth Hughes Ph.D. | Chief Operating Officer | 266.57k | -- | -- |
| Dr. Mark Luscher Ph.D. | Senior Vice President of Scientific Affairs | 249.29k | -- | -- |
| Mr. Philip Casselli | Senior Vice President of Sales, Business Development & Marketing | 265.1k | -- | -- |
| Mr. Christopher B. Lobb | Compliance Officer, General Counsel & Secretary | -- | -- | -- |
Microbix Biosystems Inc.
- Sector:?
- Healthcare
- Industry:? Biotechnology
Description
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Corporate Governance
Upcoming Events
December 19, 2024 at 1:30 PM UTC - December 23, 2024 at 1:30 PM UTC
Microbix Biosystems Inc. Earnings Date
Recent Events
September 2, 1999 at 12:00 AM UTC
Ex-Dividend Date